Alternative pol kappa nucleotide and amino acid sequence and methods for using
OwnerJuan Sausinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides isolated nucleic acid sequences and expression vectors encoding the pol κC76, substantially purified pol κ76, and methods for detecting pol κ76.
Claims12
An isolated nucleic acid consisting of a sequence that encodes a polypeptide with the amino acid sequence of SEQ ID NO:31.
A isolated polypeptide, consisting of the amino acid sequence of SEQ ID NO:31.
A method for detecting a polypeptide consisting of the amino acid sequence of SEQ ID NO:31, comprising
- a) providing a protein sample to be screened;
- b) contacting the protein sample to be screened with an antibody that selectively recognizes the polypeptide consisting of the amino acid sequence of SEQ ID NO:31 under conditions that promote antibody-polypeptide complex formation;
- and
- c) detecting the formation of an antibody-polypeptide complexes, wherein the presence of the antibody-polypeptide complexes indicates the presence of the polypeptide consisting of the amino acid sequence of SEQ ID NO:31.
A method for detecting in a sample a nucleic sequence consisting of the sequence of SEQ ID NO:30, comprising
- a) contacting the sample with one or more oligonucleotides that can be used to generate polymerase chain reaction products that selectively identify the nucleic acid sequence of SEQ ID NO:30;
- b) carrying out a polymerase chain reaction to generate the polymerase chain reaction products;
- and
- c) identifying the polymerase chain reaction products as being specific for the nucleic acid sequence of SEQ ID NO:30
A method for detecting an autoimmune condition in a patient, comprising
- a) providing a tissue or body fluid sample from the patient;
- b) providing a control tissue or body fluid sample in which no autoimmune condition is present;
- and
- c) detecting an increase in pol κ76 RNA expression in the tissue or body fluid sample compared to the control sample, wherein the increase indicates the presence of an autoimmune condition.
A method for treating a patient with an autoimmune disorder or cancer, comprising modifying the expression or activity of pol κ76 in the patient.
Dependencies are inferred from the claim text.